摘要
目的:探究妊娠合并哮喘患者通过布地奈德联合特布他林雾化吸入治疗后取得的临床成效。方法:选取我院2011年1月-2016年6月诊治的妊娠合并哮喘患者56例,随机分为观察组和对照组各28人。对照组治疗方法为特布他林雾化吸入治疗,观察组为布地奈德联合特布他林雾化吸入治疗。从治疗有效率方面入手,对两组患者进行对比分析。结果:在治疗效果方面,观察组治疗总有效率(92.9%)比对照组(71.4%)高(P<0.05)。结论:妊娠合并哮喘患者通过布地奈德联合特布他林雾化吸入治疗后,能够有效提高治疗效果,值得推广应用。
Objective: To explore the clinical efficacy of aerosol inhalation of budesonide combined with terbutaline in pregnant women with asthma. Methods: 56 cases of pregnant women with asthma treated in our hospital from January 2011 to June 2016 were randomly divided into observation group and control group. The control group was treated with atomized inhalation of terbutaline, and the observation group was treated with atomized inhalation of budesonide combined with terbutaline. From the aspects of treatment efficiency, the two groups of patients were compared and analyzed. Results: In the treatment effect, the total effective rate of treatment group(92.9%) was higher than that of the control group(71.4%)(P <0.05). Conclusion: Inhalation of budesonide combined with terbutaline can improve the therapeutic effect of pregnant women with asthma, and it is worthy of popularization and application.
出处
《中国妇幼健康研究》
2017年第S1期450-451,共2页
Chinese Journal of Woman and Child Health Research
